FDA Adverse Event Death Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 2517915 · Received April 5, 2012

Report

Report Number
2531779-2012-02821
Event Type
Death
Date Received
April 5, 2012
Date of Event
December 30, 2011
Report Date
March 8, 2012
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PUMP HAS BEEN RETURNED TO ANIMAS. EVALUATION HAS NOT YET BEEN COMPLETED. WHEN EVALUATION IS COMPLETE, A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSION CAN BE MADE AT THIS TIME. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. (B)(6).

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATION: THE PUMP HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2012 WITH THE FOLLOWING FINDINGS: A REVIEW OF THE TOTAL DAILY DOSE HISTORY INDICATED THAT INSULIN DELIVERY TOTALS CORRECTLY REFLECTED PROGRAMMED VALUES. THE PUMP WAS EXERCISED FOR 29 HOURS WITH NO DELIVERY ISSUES. AN EZPRIME OPERATION WAS PERFORMED WITH NO DIFFICULTIES, AND THE UNITS REMAINING WERE CORRECTLY CALCULATED AND RECORDED IN THE PUMP HISTORY. THE PUMP WAS EVALUATED AND FOUND TO BE OPERATING WITHIN REQUIRED SPECIFICATIONS AND DELIVERING INSULIN ACCURATELY. A REVIEW OF THE PUMP HISTORY INDICATED TIME AND DATE DEFAULTING TO FACTORY SETTINGS WHICH COULD NOT BE DUPLICATED ON INVESTIGATION.

Description of Event or Problem · 1

ON (B)(6) 2012, THE REPORTER CONTACTED ANIMAS IN RESPONSE TO AN ANIMAS MAILING AND STATED THAT THE PATIENT HAD DIED AT HOME ON (B)(6) 2011. THE REPORTER STATED THAT THE PATIENT HAD A HISTORY OF LUNG CANCER FOR 30 YEARS AND THAT THE PATIENT WAS USING THE PUMP FOR SANDOSTATIN INFUSION. THE REPORTER STATED THAT THE PATIENT'S DEATH WAS NOT RELATED TO PUMP USE, AND THAT THE CAUSE OF DEATH LISTED ON THE DEATH CERTIFICATE WAS PULMONARY CARDIAC ARREST AND END STAGE LIVER FAILURE. THIS INCIDENT IS BEING REPORTED BASED ON THE FOLLOWING CONCLUSION: EVEN THOUGH THE PATIENT'S CAUSE OF DEATH WAS UNRELATED TO DIABETES, THE PATIENT WAS KNOWN TO HAVE USED THE INSULIN PUMP TO DELIVER A DRUG THAT IS NOT APPROVED FOR USE IN THIS DEVICE

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION ONETOUCH PING INSULIN PUMP

Patients

Seq Age Sex Outcome Treatment
1 68 YR Death